Resources with keywords: facemask
n participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated
Barrios LC, Riggs MA, Green RF, et al.
Best practices for the use for the use of face coverings to maximize safety and stop the spread of disease.
Verma S, et al.
Qualitative effectiveness of face covers
Konda A, Prakash A, et al.

